World’s largest single-use plant begins cGMP production

By Dan Stanton contact

- Last updated on GMT

GettyImages/gabriel__bostan
GettyImages/gabriel__bostan

Related tags: Biotechnology

WuXi Biologics says its 30,000L capacity single-use facility in China has commenced making products for its partner Tesaro.

WuXi Biologics began building a $150m (127m) single-use site in WuXi City, China back in 2015​ and today announced it has initiated cGMP production at the plant.

The site consists of two 1,000L single-use bioreactors for perfusion processes alongside 14 2,000L fed-batch cell culture disposable vessels, supplied by Thermo Fisher​, though a spokesperson from WuXi told us other vendors have also equipped the site.

The company has “the ambition to be one of the global leaders in commercial manufacturing,” and the commencement of operations at the world’s largest single-use facility supports this, the spokesperson said.

Utilisation

We were also told the 30,000L capacity was “mostly filled”​ through current customer demand, and WuXi has a target 80% utilisation rate at the site.

The first product to be made at the site is one for its customer Tesaro, though the specific molecule and quantity was not disclosed by the spokesperson.

The Waltham, Massachusetts-based oncology-focused biopharmaceutical company has a strategic partnership with WuXi, and Tesaro’s candidate TSR-022, a monoclonal antibody targeting TIM-3 is made using the CDMO’s biologics platform.

Related news

Show more

Related products

show more

CadenceILC_610x343

Inline concentration improves process economics

Pall Biotech | 15-Jun-2018 | Case Study

Would you like to enhance your downstream process, increase production capacity and reduce costs? This case study application note demonstrates how implementing...

Cultivation of 3D Cell Aggregates in Perfusion

Cultivation of 3D Cell Aggregates in Perfusion

Eppendorf for Bioprocess – Solutions that grow with you | 21-May-2018 | Application Note

3D cell aggregates are of great interest for applications like disease modeling and manufacturing of stem cell-based products. Read more about the cultivation...

High-Density Vero Cell Perfusion Culture

High-Density Vero Cell Perfusion Culture

Eppendorf for Bioprocess – Solutions that grow with you | 01-May-2018 | Application Note

Viral diseases like rabies, rotavirus and influenza are causing many deaths worldwide, resulting in a strong demand for more productive manufacturing techniques...

Related suppliers

Follow us

Products

View more